Influenza Market Investment opportunities
Global Influenza Market is expected to reach USD 9.33 billion by 2021 from USD 5.97 billion in 2016, growing at a CAGR of 8.54% during the forecast period, 2016-2021.
(EMAILWIRE.COM, October 06, 2017 ) Influenza or flu is a transmittable respiratory disease which affect nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be either seasonal, pandemic, or zoonotic. Influenza market can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. According to World Health Organization, the flu occurs annually infecting 5% to 10% adults and 20% to 30% children, worldwide. Approximately, 3 to 5 million people gets severely infected resulting in 250,000 – 500,000 deaths. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
View Full Report @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries are not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 50% in 2016.
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
View Full Report @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries are not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 50% in 2016.
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results